U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Colistimethate – Injection products
  1. Development Resources

Colistimethate – Injection products

Exceptions to the recognized standard of CLSI M100

For these bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:

Acinetobacter spp.

Enterobacteriaceae

Pseudomonas aeruginosa

Back to Top